Global X Genomics & Biotechnology ETF Rating $53.92 -0.98 (-1.79%) As of 07/24/2026 03:57 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsTrendsBuy This Stock Global X Genomics & Biotechnology ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.GNOM Aggregate RatingModerate Buy 2.58Holdings in GNOM have an aggregate rating of Moderate Buy based on 441 analyst ratings issued in the past year covering 24 companies (81.0% of the portfolio).GNOM Aggregate Price Target$53.92High Prediction$53.92Average Prediction$53.92Low Prediction$53.92Holdings in GNOM have an aggregate price target of $53.92 and a range of $53.92 to $53.92 covering 24 companies (81.0% of the portfolio).GNOM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Global X Genomics & Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 GNOM Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.22%GHGuardant Health$147.33-1.9%3.1621 of 5 stars2.96$160.04 8.6%25News CoveragePositive NewsUpcoming Earnings4.90%ILMNIllumina$194.09-1.4%2.344 of 5 stars2.37$156.88 -19.2%19Trending NewsUpcoming Earnings4.86%TWSTTwist Bioscience$90.27-2.3%1.5508 of 5 stars2.70$90.30 0.0%10Positive News4.62%TXG10x Genomics$46.27-3.7%1.8955 of 5 stars2.20$32.08 -30.7%154.56%NTRANatera$261.99-1.0%3.2615 of 5 stars2.82$267.83 2.2%22Positive News4.20%MRNAModerna$54.07-5.2%1.5748 of 5 stars1.82$40.00 -26.0%17Upcoming EarningsAnalyst ForecastGap Down4.17%TECHBio-Techne$71.60-0.2%2.6705 of 5 stars2.12$68.08 -4.9%17Positive News4.14%VCYTVeracyte$56.61-2.2%1.7988 of 5 stars2.60$55.88 -1.3%10Upcoming Earnings3.73%VRTXVertex Pharmaceuticals$477.36+0.9%4.2749 of 5 stars2.88$559.61 17.2%25Positive News3.72%BMRNBioMarin Pharmaceutical$59.33+0.8%4.5077 of 5 stars2.71$88.26 48.8%24News CoveragePositive News3.53%QGENQiagen$41.38-0.2%3.9593 of 5 stars2.36$43.34 4.8%14News CoveragePositive News3.32%ARWRArrowhead Pharmaceuticals$85.60-1.4%1.8941 of 5 stars2.71$93.83 9.6%14News CoverageAnalyst Forecast3.23%PRAXPraxis Precision Medicines$325.30+0.9%4.0794 of 5 stars2.95$563.50 73.2%22Positive News3.11%CRSPCRISPR Therapeutics$46.54-2.1%3.3742 of 5 stars2.58$67.78 45.6%19News CoverageAnalyst Forecast3.04%LEGNLegend Biotech$22.22-5.6%2.927 of 5 stars2.50$55.38 149.3%14Analyst DowngradeGap Down2.90%BNTXBioNTech$89.33-3.0%4.1865 of 5 stars2.74$129.13 44.5%192.64%RAREUltragenyx Pharmaceutical$26.90-0.4%3.8483 of 5 stars2.83$58.41 117.1%18News CoveragePositive NewsOptions Volume2.56%BEAMBeam Therapeutics$25.10-3.1%2.5366 of 5 stars2.64$46.85 86.6%14News Coverage2.29%BLLNBilliontoone$126.08-2.2%2.1383 of 5 stars2.50$126.00 -0.1%102.13%LLYEli Lilly and Company$1,196.18+0.9%3.7482 of 5 stars2.87$1,283.64 7.3%31Trending News2.03%QUREuniQure$38.97-1.2%3.4034 of 5 stars2.65$64.17 64.7%17News CoverageUpcoming Earnings1.88%CAICaris Life Sciences$15.52-0.8%4.7728 of 5 stars2.45$26.11 68.2%111.69%GILDGilead Sciences$129.31-1.2%4.9229 of 5 stars2.86$158.33 22.4%29Analyst Downgrade1.57%SRPTSarepta Therapeutics$15.68-1.3%3.0008 of 5 stars2.08$23.90 52.5%25 This page (NASDAQ:GNOM) was last updated on 7/25/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredBofA: Digital Dollar Coming 2025-2030Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | SponsoredWhere to Put $100 Before Trump's New Tech Law Rolls OutThe Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNOM Stock Alerts